Nicholson Garry A Insider Trades

Insider Trading History

Track insider trading activity for Nicholson Garry A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tscan Therapeutics
Tscan Therapeutics TCRX
Director
Holding Value $61.7k 67,000 shares
Last Trade
May 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66.3k 67,000 shares
$0.99
$0.92
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Director
Holding Value $0 0 shares
Last Trade
Apr 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.5M 69,835 shares
$21.53
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Director
Holding Value $807k 37,500 shares
Last Trade
Nov 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$933k 103,735 shares
$8.99
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Director
Holding Value $0 0 shares
Last Trade
Nov 06, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$933k 103,735 shares
$8.99
$21.53
Tscan Therapeutics
Tscan Therapeutics TCRX
Director
Holding Value $61.7k 67,000 shares
Last Trade
Jun 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$97.2k 67,000 shares
$1.45
$0.92
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Director
Holding Value $484k 22,500 shares
Last Trade
Jun 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$158k 22,500 shares
$7.01
$21.53
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $0 0 shares
Last Trade
Sep 18, 2024 Sale (Tender)Reported as Tender on SEC Form 4.
$103k 14,389 shares
$7.16
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $103k 14,389 shares
Last Trade
Sep 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$788k 110,000 shares
$7.16
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $246k 34,389 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.7k 30,000 shares
$2.99
$7.16
Tscan Therapeutics
Tscan Therapeutics TCRX
Director
Holding Value $43.7k 47,500 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$633k 71,250 shares
$8.88
$0.92
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Director
Holding Value $696k 32,335 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$448k 32,335 shares
$13.87
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Director
Holding Value $807k 37,500 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$476k 37,500 shares
$12.69
$21.53
Nextcure
Nextcure NXTC
Director
Holding Value $25.4k 14,250 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$277k 14,250 shares
$19.44
$1.78
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $215k 30,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84.9k 30,000 shares
$2.83
$7.16
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Director
Holding Value $730k 33,900 shares
Last Trade
Sep 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$876k 33,900 shares
$25.84
$21.53
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Director
Holding Value $0 0 shares
Last Trade
Aug 17, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.78M 23,400 shares
$76.01
$75.49
Nextcure
Nextcure NXTC
Director
Holding Value $25.4k 14,250 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$816k 14,250 shares
$57.24
$1.78
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $103k 14,389 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$53k 10,000 shares
$5.30
$7.16
Nextcure
Nextcure NXTC
Director
Holding Value $25.4k 14,250 shares
Last Trade
Jun 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.4M 14,250 shares
$98.52
$1.78
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $140k 19,620 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$431k 19,620 shares
$21.97
$7.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up